Outcome of Mammary Prostheses Explanation

Svahn, Jennifer K.; Vastine, Victoria L.; Landon, Bruce N.; Dobke, Marek

doi:10.1097/00000637-199606000-00006

Cited by 12 publications

(7 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Svahn et al retrospectively studied health improvement following removal of silicone gel-filled breast implants in 63 female patients [31]. Quality of life was assessed by a questionnaire in which physical and cognitive function was studied.…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Is explantation of silicone breast implants useful in patients with complaints?

et al. 2016

View full text Add to dashboard Cite

In this review, we present a critical review of the existing literature reflecting the results of explantation of silicone breast implants in patients with silicone-related complaints and/or autoimmune diseases. A literature search was performed to discuss the following issues: which clinical manifestations and autoimmune diseases improve after explantation, and what is the course of these complaints after explantation. Next, we reviewed studies in which the effect of explantation on laboratory findings observed in patients with silicone breast implants was studied, and lastly, we reviewed studies that described the effect of reconstruction of the breast with a new implant or autologous tissue after explantation. We calculated from the literature that explantation of the silicone breast improved silicone-related complaints in 75 % of the patients (469 of 622). In patients with autoimmune diseases, however, improvement was only infrequently observed without additional therapy with immunosuppressive therapy, i.e., in 16 % of the patients (3 of 18). The effect of explantation did not influence autoantibody testing such as ANA. We discuss several possibilities which could clarify why patients improve after explantation. Firstly, the inflammatory response could be reduced after explantation. Secondly, explantation of the implants may remove a nociceptive stimulus, which may be the causative factor for many complaints. Options for reconstruction of the explanted breast are autologous tissue and/or water-/hydrocellulose-filled breast implant. Unfortunately, in very few studies attention was paid to reconstructive possibilities. Therefore, no adequate conclusion regarding this issue could be drawn. In conclusion, explantation is useful for improvement of silicone-related complaints in 75 % of the patients, whereas in patients who developed autoimmune diseases improvement is only observed when explantation is combined with immunosuppressive therapy. In a patient with silicone-related complaints in which explantation is considered, the patient should be counseled for the different options of reconstruction after explantation.

show abstract

Section: Resultsmentioning

confidence: 99%

“…For 603 patients, it was well described whether clinical status improved after explantation [25–28, 31–35]. Of 603 patients, 457 (76 %) experienced improvement of silicone-related complaints after explantation.…”

Section: Resultsmentioning

confidence: 99%

Is explantation of silicone breast implants useful in patients with complaints?

et al. 2016

View full text Add to dashboard Cite

show abstract

mentioning

confidence: 99%

“…Considering the fact that immune alterations and chronic inflammatory profiles may have a similar pathophysiology regardless of whether reactions are considered ''local'', and limited to the surrounding breast environment, or systemic; the hypothesis that capsular contracture and breast implant illness share the same initial pathogenesis and are on a continuum of the same chronic inflammatory spectrum is reasonable [22][23][24][25][26]. The combination of the presence of toxic or immunizing-capable detachment molecules from Staphylococcus epidermidis biofilms as well as some silicone gel adjuvant potency may lead to different reactions ranging from local-in some circumstances unilateralfibrosis (capsular contracture) through systemic ones (fibromyalgia, BII) [10, [22][23][24][25][26][27]. Therefore, it should not be surprising that the outcomes from implant explanation or periprosthetic capsulectomy are inconsistent and often not permanent-once the systemic inflammatory cascade is activated, it tends to have its own dynamic course and the elimination of antigens and the site of local inflammation may not result in the resolution of the multitude of symptoms and problems that may be present [4,17,18,[22][23][24][25][26].…”

mentioning

confidence: 99%

“…The combination of the presence of toxic or immunizing-capable detachment molecules from Staphylococcus epidermidis biofilms as well as some silicone gel adjuvant potency may lead to different reactions ranging from local-in some circumstances unilateralfibrosis (capsular contracture) through systemic ones (fibromyalgia, BII) [10, [22][23][24][25][26][27]. Therefore, it should not be surprising that the outcomes from implant explanation or periprosthetic capsulectomy are inconsistent and often not permanent-once the systemic inflammatory cascade is activated, it tends to have its own dynamic course and the elimination of antigens and the site of local inflammation may not result in the resolution of the multitude of symptoms and problems that may be present [4,17,18,[22][23][24][25][26].…”

mentioning

confidence: 99%

See 1 more Smart Citation

Subclinical Infection of the Silicone Breast Implant Surface as a Possible Cause of Capsular Contracture: A Follow-Up

2020

View full text Add to dashboard Cite

Late Intracapsular Seroma in Subfascial Buttock Augmentation: A Case Report

González

2006

Aesth Plast Surg

View full text Add to dashboard Cite

Late intracapsular seroma and hematoma have been described frequently as a complication of breast augmentation surgery. However, there are few reports of late intracapsular seroma in buttock augmentation. Textured and polyurethane implants have been used for subfascial enlargement of the buttocks. In this article, the authors report a large late intracapsular bilateral seroma caused by a retrofascial polyurethane-covered implant used for buttock augmentation: 1,200 ml on one side and 300 ml on the other. This patient's intracapsular seroma was of sudden onset 2 years and 6 months after surgery, and apparently had no relation to any trauma, use of medication, or physical exercise. Local tissues, including the gluteal fascia, were distended such that the implant was replaced inside the muscle and there was no relapse of the seroma. Late intracapsular hematomas or seromas from implants for buttock and breast augmentation may have the same etiology, and textured implants seem to be involved. All the reports on the matter are associated with textured implants. Any late seroma or hematoma caused by a smooth implant is related to an additional factor that may be considered as the etiologic agent. Further studies aimed at a large-scale assessment of the cause and actual incidence of late seromas and hematomas from textured implants are required.

show abstract

Outcome of Mammary Prostheses Explanation

Cited by 12 publications

References 0 publications

Is explantation of silicone breast implants useful in patients with complaints?

Is explantation of silicone breast implants useful in patients with complaints?

Subclinical Infection of the Silicone Breast Implant Surface as a Possible Cause of Capsular Contracture: A Follow-Up

Late Intracapsular Seroma in Subfascial Buttock Augmentation: A Case Report

Contact Info

Product

Resources

About